Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cellsJordi Codony‐Servat, Joan Albanell|Molecular Cancer Therapeutics|2006Cited by 107
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancerJordi Codony‐Servat, Joan Maurel|British Journal of Cancer|2017Cited by 76
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell linesJordi Codony‐Servat, Rafael Rosell|Translational Lung Cancer Research|2019Cited by 17